Finding Alternatives to Standard Treatment for Attention-Deficit Hyperactivity Disorder
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age9-15
SponsorUniversity of Calgary
About this trial
Attention-Deficit/Hyperactivity Disorder (ADHD) is characterized by poor attention, impulsivity, hyperactivity and emotional-motivational dysregulation. Here, we will test if theta burst repetitive transcranial magnetic stimulation (rTMS) can reduce the symptoms of ADHD.
Eligibility criteria
Qualifiers
Diagnosis of ADHD
9-15 years old
IQ greater than 80
English fluency (to enable consent/assent)
Disqualifiers
Diagnosis of mania, psychosis, or bipolar disorder
Impediments to TMS or MRI (i.e. metal implants in body)
Prior electroconvulsive therapy or vagus nerve stimulation
Diagnosis of Autism Spectrum Disorder.
Trial design
Treatments tested in this trial
- rTMS
Treatment groups
30 Participants
are divided into 1 treatment groupLocations
1Alberta Children's HospitalT3B 6A8, CalgaryAlberta, Canada
Sponsors and collaborators
University of Calgary
Lead sponsor
Source ClinicalTrials.gov